14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
TAYD vs DECT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Taylor Devices Inc (TAYD) is the stronger overall head-to-head candidate over AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TAYD carries a Unified Composite Score of 52.1/100 (HOLD) at $56.85 (14.8x Forward P/E, 13.2% operating margin), whereas DECT carries 59.0/100 (HOLD) at $39.24 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While DECT currently prints a higher short-term Unified Composite Score (59.0/100 HOLD vs. TAYD 52.1/100 HOLD), TAYD captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (13.2% vs. N/A operating margin) and revenue trajectory (-26.4% vs. N/A YoY).
Technical & Structure Timing Caution: TAYD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.9); meanwhile DECT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 39.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TAYD vs DECT. Trailing 12-month operating profitability (TAYD 13.2% vs DECT N/A) and valuation multiples (TAYD 14.8x vs DECT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ TAYD vs DECT Key Questions & Quantitative Answers
As of Nov 16, 2026, Taylor Devices Inc (TAYD) is the stronger overall head-to-head candidate over AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TAYD carries a Unified Composite Score of 52.1/100 (HOLD) at $56.85 (14.8x Forward P/E, 13.2% operating margin), whereas DECT carries 59.0/100 (HOLD) at $39.24 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While DECT currently prints a higher short-term Unified Composite Score (59.0/100 HOLD vs. TAYD 52.1/100 HOLD), TAYD captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (13.2% vs. N/A operating margin) and revenue trajectory (-26.4% vs. N/A YoY). Technical & Structure Timing Caution: TAYD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.9); meanwhile DECT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 39.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TAYD leads the Growth & Scale pillar: TAYD posts -26.4% YoY revenue growth and -79.7% YoY earnings growth on $39M TTM revenue (41.2% gross margin, 13.2% operating margin), compared with DECT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, TAYD generates $39M in USD-normalized revenue versus N/A for DECT. In operating R&D and SG&A reinvestment, TAYD deploys 28.0% of Rev ($11M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DECT.
TAYD screens cheaper on headline valuation multiples. TAYD trades at 14.8x Forward P/E, 28.1x Trailing P/E, N/M PEG, and 4.8x EV/Revenue (9.3% FCF margin), whereas DECT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TAYD (9.9% ROE) versus DECT (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, TAYD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 38% Vol realized risk). By comparison, DECT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.70β · 19% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.